Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Terry Stone

Managing Partner, Americas, Oliver Wyman

How organizations are wresting with back-to-work plans in light of the Delta variant.

Managing Partner, Americas, Oliver Wyman

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

An Analysis of Infection Odds Based on US County

Our new model projects the chance that within a gathering of random people, there's an active COVID-19 infection.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Timeline to Normalcy - Updated March 15, 2021

Our revised analysis and state-by-state outlook suggest the US may achieve pHIT in early summer if vaccinations align with a more optimistic scenario.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Female CEOs on Leadership, Transformation, and the Path Forward for Parity

Our new gender parity research focuses on nine leaders who defied the odds to transform their organization and industry.

Managing Partner, Americas, Oliver Wyman

Insights in your inbox

Subscribe

Five Healthcare Predictions

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

Timeline to Normalcy - Updated January 25, 2021

The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Featured in The Dallas Morning News

Executives who care about diversity should examine the track in their companies to senior management.

Managing Partner, Americas, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

Insights in your inbox

Subscribe